학술논문

Real world evidence of progression independent of relapsing activity among ms patients treated with alemtuzumab
Document Type
Journal
Source
MULTIPLE SCLEROSIS JOURNAL; DEC 2020, 26 3_SUPPL, p547-p547, 1p. Supplement: 3_
Subject
Language
English
ISSN
14770970